Supplemental Figure 6 from IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR

Authors :: Jin Q. Cheng
Eric B. Haura
Domenico Coppola
Douglas W. Cress
Matthew A. Smith
Donghwa Kim
Yajuan Li
Cheng-Xiong Xu
Xiaowen Ding
Jian-Ping Guo
Sridevi Challa
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: IKBKE inhibitor amlexanox induces G1 arrest and pERK

Full Text Access

Tools